EDGAR Filing Documents for 0001493152-17-005563

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001493152-17-005563

Filing Date

2017-05-17

Accepted

2017-05-17 17:29:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		sc13g.htm	SC 13G	129361
2		ex1.htm	EX-1	4925
	Complete submission text file	0001493152-17-005563.txt		136059

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85963 | Film No.: 17852800
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019

Business Address 250 WEST 55TH STREET 16TH FLOOR, SUITE A NEW YORK NY 10019 646-597-6980

RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G